Wunderlich Capital Managemnt Vertex Pharmaceuticals Inc Transaction History

Wunderlich Capital Managemnt

$212 Million
Q2 2024

A detailed history of Wunderlich Capital Managemnt transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wunderlich Capital Managemnt holds 1,211 shares of VRTX stock, worth $559,130. This represents 0.27% of its overall portfolio holdings.

Number of Shares

1,211

Previous 1,221 0.82%

Holding current value

$559,130

Previous $510,000 11.18%

% of portfolio

0.27%

Previous 0.24%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $3,928 - $4,855	-10 Reduced 0.82%	1,211 $567,000
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $20,792 - $22,750	-51 Reduced 4.01%	1,221 $510,000
Q4 2023 Feb 15, 2024	BUY	$343.0 - $410.68 $8,575 - $10,267	25 Added 2.0%	1,272 $517,000
Q3 2023 Nov 15, 2023	BUY	$338.18 - $362.46 $274,940 - $294,679	813 Added 187.33%	1,247 $433,000
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $291,849 - $312,802	-863 Reduced 66.54%	434 $434,000
Q2 2023 Aug 08, 2023	SELL	$314.42 - $351.91 $628 - $703	-2 Reduced 0.15%	1,297 $456,000
Q1 2023 May 09, 2023	BUY	$283.23 - $323.1 $18,693 - $21,324	66 Added 5.35%	1,299 $409,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $16,002 - $18,002	56 Added 4.76%	1,233 $356,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $52,849 - $58,967	193 Added 19.61%	1,177 $341,000
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $39,238 - $48,855	167 Added 20.44%	984 $277,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $5,756 - $6,785	26 Added 3.29%	817 $213,000
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $140,014 - $176,748	791 New	791 $174,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $1.44 Million - $1.61 Million	-7,947 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$187.49 - $221.1 $32,435 - $38,250	173 Added 2.23%	7,947 $1.6 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $1.61 Million - $1.88 Million	7,774 New	7,774 $1.67 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wunderlich Capital Managemnt, based on Form 13F filings with the SEC.

News

Stay updated on Wunderlich Capital Managemnt with notifications on news.

Account

Wunderlich Capital Managemnt Vertex Pharmaceuticals Inc Transaction History